Skip to Main Content

Paper Details

Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.
Eur Respir J
17
2022
Author NameAffiliation
Tom van der Polllocation University of Amsterdam, Center for Experimental and Molecular Medicine (CEMM)
Lieuwe D J Boslocation University of Amsterdam
Lieuwe D J Boslocation University of Amsterdam
  • 1 - 3

Datasets